These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 8611078)

  • 21. [Aspects of the antimicrobial resistence profile in infections with Escherichia coli and Klebsiella pneumoniae in diabetic patients].
    Petrovici CG; Dorobăţ C; Matei M; Teodor A; Luca V; Miftode E
    Rev Med Chir Soc Med Nat Iasi; 2011; 115(3):769-75. PubMed ID: 22046785
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Once versus thrice daily tobramycin alone and in combination with ceftazidime, ciprofloxacin and imipenem in an in vitro pharmacodynamic model.
    Zelenitsky SA; Karlowsky JA; Hoban DJ; Kabani A; Zhanel GG
    Chemotherapy; 1998; 44(1):1-6. PubMed ID: 9444401
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of different types and combinations of antimicrobial agents on endotoxin release from gram-negative bacteria: an in-vitro and in-vivo study.
    Dofferhoff AS; Nijland JH; de Vries-Hospers HG; Mulder PO; Weits J; Bom VJ
    Scand J Infect Dis; 1991; 23(6):745-54. PubMed ID: 1815338
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical and economic evaluation of subsequent infection following intravenous ciprofloxacin or imipenem therapy in hospitalized patients with severe pneumonia.
    Caldwell JW; Singh S; Johnson RH
    J Antimicrob Chemother; 1999 Mar; 43 Suppl A():129-34. PubMed ID: 10225583
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recombinant endotoxin neutralizing protein improves survival from Escherichia coli sepsis in rats.
    Nelson D; Kuppermann N; Fleisher GR; Hammer BK; Thompson CM; Garcia CT; Novitsky TJ; Parsonnet J; Onderdonk A; Siber GR
    Crit Care Med; 1995 Jan; 23(1):92-8. PubMed ID: 8001394
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibiotic-induced release of endotoxin from bacteria in vitro.
    Crosby HA; Bion JF; Penn CW; Elliott TS
    J Med Microbiol; 1994 Jan; 40(1):23-30. PubMed ID: 8289210
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk of endotoxemia during the initial phase of gut decontamination with antimicrobial agents.
    Schulze C; Oesser S; Hein H; Seifert J
    Res Exp Med (Berl); 2001 Mar; 200(3):169-74. PubMed ID: 11426668
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical consequences of increased ciprofloxacin and gentamicin resistance in patients with Escherichia coli bacteraemia in the Netherlands.
    Cranendonk DR; van der Valk M; Langenberg ML; van der Meer JT
    Scand J Infect Dis; 2012 May; 44(5):363-8. PubMed ID: 22200089
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of in-vivo endotoxin liberation on anti-anaerobic antimicrobial efficacy.
    Rotimi VO; Al-Sweih NN; Anim JT; Ahmed K; Verghese TL; Khodakhast FB
    J Chemother; 2001 Oct; 13(5):510-8. PubMed ID: 11760215
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic efficacy of the polymyxin-like peptide ranalexin in an experimental model of endotoxemia.
    Ghiselli R; Giacometti A; Cirioni O; Orlando F; Mocchegiani F; Pacci AM; Scalise G; Saba V
    J Surg Res; 2001 Oct; 100(2):183-8. PubMed ID: 11592790
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dose response of experimental Pseudomonas endophthalmitis to ciprofloxacin, gentamicin, and imipenem: evidence for resistance to "late" treatment of infections.
    Davey PG; Barza M; Stuart M
    J Infect Dis; 1987 Mar; 155(3):518-23. PubMed ID: 3100661
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Investigation of the potential role of Enterococcus faecalis in the pathophysiology of experimental peritonitis.
    Montravers P; Andremont A; Massias L; Carbon C
    J Infect Dis; 1994 Apr; 169(4):821-30. PubMed ID: 8133097
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo significance of the inoculum effect of antibiotics on Escherichia coli.
    Soriano F; Santamaría M; Ponte C; Castilla C; Fernández-Roblas R
    Eur J Clin Microbiol Infect Dis; 1988 Jun; 7(3):410-2. PubMed ID: 3137046
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibiotic prophylaxis for ERCP: a comparison of oral ciprofloxacin with intravenous cephazolin in the prophylaxis of high-risk patients.
    Davis AJ; Kolios G; Alveyn CG; Robertson DA
    Aliment Pharmacol Ther; 1998 Mar; 12(3):207-11. PubMed ID: 9570254
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prospective, randomized, controlled study comparing two dosing regimens of gentamicin/oral ciprofloxacin switch therapy for acute pyelonephritis.
    Bailey RR; Begg EJ; Smith AH; Robson RA; Lynn KL; Chambers ST; Barclay ML; Hornibrook J
    Clin Nephrol; 1996 Sep; 46(3):183-6. PubMed ID: 8879853
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mortality rate and bacteremia, endotoxin, and endothelin-1 levels in antibiotic therapy for E. coli septic peritonitis.
    Tsukada K; Katoh H; Shiojima M; Takenoshita S; Nagamachi Y
    APMIS; 1993 Feb; 101(2):97-100. PubMed ID: 8489768
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bacterial killing by use of once daily gentamicin dosage in guinea pigs with Escherichia coli infection.
    Campbell BG; Bartholow S; Rosin E
    Am J Vet Res; 1996 Nov; 57(11):1627-30. PubMed ID: 8915442
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Local treatment of generalised peritonitis in rats; effects on bacteria, endotoxin and mortality.
    Rosman C; Westerveld GJ; Kooi K; Bleichrodt RP
    Eur J Surg; 1999 Nov; 165(11):1072-9. PubMed ID: 10595613
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of changes in pancreatic tissue morphology and capillary blood flow on antibiotic tissue concentrations in the pancreas during the progression of acute pancreatitis.
    Foitzik T; Hotz HG; Kinzig M; Sörgel F; Buhr HJ
    Gut; 1997 Apr; 40(4):526-30. PubMed ID: 9176083
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of the combination of tachyplesin III and clarithromycin in rat models of Escherichia coli sepsis.
    Cirioni O; Ghiselli R; Silvestri C; Kamysz W; Orlando F; Riva A; Kamysz E; Castelletti S; Rocchi M; Saba V; Scalise G; Giacometti A
    Antimicrob Agents Chemother; 2008 Dec; 52(12):4351-5. PubMed ID: 18779356
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.